Moneycontrol
Last Updated : Sep 28, 2017 01:08 PM IST | Source: Moneycontrol.com

Dishman Carbogen Amcis spikes 5% on zero observations from USFDA for Switzerland unit

Wholly owned subsidiary, Carbogen Amcis AG's manufacturing site in Bubendorf, Switzerland, has successfully completed a routine US Food and Drug Administration (FDA) inspection.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dishman Carbogen Amcis (erstwhile Dishman Pharma) rallied 5 percent intraday Thursday after its Switzerland unit received zero observations from the US health regulator

The company informed exchanges that its wholly owned subsidiary, Carbogen Amcis AG's manufacturing site in Bubendorf, Switzerland, has successfully completed a routine US Food and Drug Administration (FDA) inspection.

The inspection was concluded without any major or critical observations or Form 483's, thus confirming that no concerns were discovered during the inspection, it said.

At 13:02 hours IST, the stock price was trading at Rs 321, up Rs 14.75 or 4.82 percent on the BSE.
First Published on Sep 28, 2017 01:08 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant